Enveda, an AI drugmaker, banks $311M in venture funding

T2Covered by 1 source · first reported by BioPharma Dive / Healthcare Dive / MedTech Dive at 23 Sept, 17:55 UTC

Enveda, which is using AI tools to mine plants and microbes for drug prospects, has three candidates in human testing for immune diseases and obesity.

science

Sources

• T2Enveda, an AI drugmaker, banks $311M in venture fundingBioPharma Dive / Healthcare Dive / MedTech Dive23 Sept, 17:55